El Naamani, Kareem
Mastorakos, Panagiotis
Adeeb, Nimer
Lan, Mathews
Castiglione, James
Khanna, Omaditya
Diestro, Jose Danilo Bengzon
McLellan, Rachel M.
Dibas, Mahmoud
Vranic, Justin E.
Aslan, Assala
Cuellar-Saenz, Hugo H.
Guenego, Adrien
Carnevale, Joseph
Saliou, Guillaume
Ulfert, Christian
Möhlenbruch, Markus
Foreman, Paul M.
Vachhani, Jay A.
Hafeez, Muhammad U.
Waqas, Muhammad
Tutino, Vincent M.
Rabinov, James D.
Ren, Yifan
Michelozzi, Caterina
Spears, Julian
Panni, Pietro
Griessenauer, Christoph J.
Asadi, Hamed
Regenhardt, Robert W.
Stapleton, Christopher J.
Ghozy, Sherief
Siddiqui, Adnan
Patel, Nirav J.
Kan, Peter
Boddu, Srikanth
Knopman, Jared
Aziz-Sultan, Mohammad A.
Zanaty, Mario
Ghosh, Ritam
Abbas, Rawad
Amllay, Abdelaziz
Tjoumakaris, Stavropoula I.
Gooch, Michael R.
Cancelliere, Nicole M.
Herial, Nabeel A.
Rosenwasser, Robert H.
Zarzour, Hekmat
Schmidt, Richard F.
Pereira, Vitor Mendes
Patel, Aman B.
Jabbour, Pascal
Dmytriw, Adam A.
,
Article History
Received: 13 February 2023
Revised: 6 April 2023
Accepted: 12 April 2023
First Online: 11 May 2023
Declarations
:
: Dr. Jabbour is a consultant for Medtronic, MicroVention, Balt, and Cerus Endovascular. Dr. Tjoumakaris is a consultant for Medtronic and MicroVention. Dr. Gooch is a consultant for Stryker. Dr. Regenhardt is DSMB member for Rapid Medical, site PI for MicroVention, and site PI for Penumbra. The other authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.